- New research has elucidated how an already identified area of the genome contributes to the development of a number of autoimmune or inflammatory diseases, including inflammatory bowel disease (IBD).
- The discovery of this genetic mechanism could help identify drugs that already exist that could be used to treat inflammatory bowel disease (IBD).
- Some experts say further studies in patients with IBD are needed to confirm if these medications have the intended effect.
Scientists at the Francis…
Read the full article here